Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HCID 17964359, 화합물 → 5-{4-[1-(2-[1,4]dioxan-2-yl-ethyl)-1H-indol-3-yl]-piperidin-1-ylmethyl}-2-methoxy-benzoic Acid
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | HCID 17964359 | HCID 17964359 | — |
| 반응물 | 5-Bromomethyl-2-methoxybenzoic acid ethyl ester | HCID 68893946 | — |
| 생성물 | 5-{4-[1-(2-[1,4]dioxan-2-yl-ethyl)-1H-indol-3-yl]-piperidin-1-ylmethyl}-2-methoxy-benzoic Acid | HCID 10162728 | — |
반응 단계
This compound was prepared following the procedure described in example 13 (part D) starting with 0.06 g (0.19 mmol) of 1-(2-[1,4]dioxan-2-yl-ethyl)-3-piperidin-4-yl-1H-indole and 0.071 g (0.26 mmol) of 5-bromomethyl-2-methoxy-benzoic acid ethyl ester. After standard purification, 0.019 g (65% of yield) were obtained.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07189741B2 |
| 출처 데이터셋 | uspto-grants-2007_03 |
| ORD ID | ord-76fd70cbd6dd45beadb426ecccc06269 |
| 출처 메모 | uspto-grants-2007_03 |